Cutler Group’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-500
Closed -$1K 5984
2017
Q2
$1K Sell
500
-6,500
-93% -$28.5K ﹤0.01% 5823
2017
Q1
$4K Buy
7,000
+4,800
+218% +$26.8K ﹤0.01% 4862
2016
Q4
$1K Buy
+2,200
New +$12K ﹤0.01% 5928
2016
Q3
Sell
-1,000
Closed -$1K 6738
2016
Q2
$1K Buy
+1,000
New +$4.35K ﹤0.01% 6012

Other funds holding CTSO

Cutler Group's CTSO Position: Q3 2022 in Review

Cutler Group sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 512 shares — an estimated $1K sold.

Cutler Group first reported a position in CTSO in Q4 2015 and held it in 5 quarters. The position peaked at $7K in Q3 2016. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • Cutler Group reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 512 Cytosorbents Corp shares in Q3 2022, an estimated $1K.
  • Cutler Group first reported a position in Cytosorbents Corp in Q4 2015 and held it in 5 quarters.
  • Cutler Group's Cytosorbents Corp position peaked at $7K in Q3 2016.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.